Reparixin, Placebo - Tablet for oral use
REP0122
Phase 2 small_molecule active
Quick answer
Reparixin, Placebo - Tablet for oral use for Acute Respiratory Distress Syndrome is a Phase 2 program (small_molecule) at Dompe' Farmaceutici S.p.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Dompe' Farmaceutici S.p.A.
- Indication
- Acute Respiratory Distress Syndrome
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active